Palmitoyl Pentapeptide-4 vs SNAP-8
A side-by-side research comparison of Palmitoyl Pentapeptide-4 and SNAP-8 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Palmitoyl Pentapeptide-4 | SNAP-8 |
|---|---|---|
| Full name | Palmitoyl Pentapeptide-4 (Matrixyl Original) | SNAP-8 (Acetyl Octapeptide-3) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Mimics collagen breakdown products (matrikines) that signal fibroblasts to produce new collagen matrix components including types I, III, and IV collagen. | More effectively competes with SNAP-25 for SNARE complex incorporation due to longer sequence, providing greater vesicle-membrane fusion inhibition. |
| Molecular weight | 802.05 Da | 1,075 Da |
| Half-life | N/A (topical depot effect) | 8-14 hours (topical) |
| Bioavailability | Topical: ~8-12% penetration | Moderate (topical) |
| Typical dose | 2-8% in formulation | 3-10% solution |
| Frequency | 2x daily | 2x daily |
| Route | Topical serum or cream | Topical |
Palmitoyl Pentapeptide-4 reported benefits
- Proven collagen stimulation
- Wrinkle depth reduction
- Improved skin firmness
- Well-tolerated
SNAP-8 reported benefits
- Superior to argireline
- Deeper wrinkle reduction
- Prevents expression lines
- Good skin penetration
Related comparisons
Research and educational reference only. Not medical advice.